- Report
- June 2025
- 150 Pages
Global
From €3392EUR$3,850USD£2,942GBP
- Report
- June 2025
- 150 Pages
Global
From €3392EUR$3,850USD£2,942GBP
- Report
- June 2025
- 150 Pages
Global
From €3392EUR$3,850USD£2,942GBP
- Report
- November 2024
- 150 Pages
Global
From €2864EUR$3,250USD£2,484GBP
€4273EUR$4,850USD£3,707GBP
- Report
- July 2025
- 277 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 455 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 464 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 166 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 370 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 378 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 479 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- October 2024
- 200 Pages
Global
From €3304EUR$3,750USD£2,866GBP
- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,825USD£2,923GBP
€3965EUR$4,500USD£3,439GBP
- Report
- June 2025
- 249 Pages
Global
From €3921EUR$4,450USD£3,401GBP
- Report
- May 2025
- 216 Pages
Global
From €2203EUR$2,500USD£1,911GBP
- Report
- December 2024
- 196 Pages
Global
From €2203EUR$2,500USD£1,911GBP
- Report
- July 2025
- 295 Pages
Global
From €4401EUR$4,995USD£3,817GBP
- Report
- June 2025
- 60 Pages
United States
From €3480EUR$3,950USD£3,019GBP
- Report
- June 2025
- 120 Pages
United States
From €5243EUR$5,950USD£4,547GBP
- Report
- April 2025
- 222 Pages
Europe
From €3084EUR$3,500USD£2,675GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more